Kate R Kuhlman1, Theodore F Robles2, Larissa N Dooley2, Chloe C Boyle2, Marcie D Haydon2, Julienne E Bower3. 1. Department of Psychology and Social Behavior, University of California Irvine, Irvine, CA 92697, United States; Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90095, United States. Electronic address: krkuhlman@ucla.edu. 2. University of California Los Angeles, Department of Psychology, Los Angeles, CA 90095, United States. 3. Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90095, United States; University of California Los Angeles, Department of Psychology, Los Angeles, CA 90095, United States.
Abstract
BACKGROUND: Inflammation plays a role in mood and behavior that may be relevant to identifying risk factors and treatment for depression and other stress-related illnesses. The purpose of this study was to examine whether fluctuations in inflammation following a mild immune stimulus were associated with changes in daily reported features of depression for up to a week in a healthy sample of young adults. METHODS: Forty-one undergraduate students completed daily diaries of mood, feelings of social disconnection, sleep, and physical symptoms for one week before and after receiving the seasonal influenza vaccine. Circulating plasma interleukin-6 (IL-6) was measured via blood samples taken immediately before and one day after vaccination. RESULTS: There was a significant increase in circulating IL-6 from pre- to post-intervention (p = .008), and there was significant variability in the magnitude of IL-6 change. Greater increases in IL-6 were associated with greater mood disturbance on post-vaccine days, specifically depressed mood and cognitive symptoms. CONCLUSIONS: Minor increases in inflammation were associated with corresponding increases in features of depression, and these associations occurred in the absence of any physical symptoms. The influenza vaccine could be used to probe causal relationships with a high degree of ecological validity, even in high-risk and vulnerable populations, to better understand the role of inflammation in the pathogenesis of depression.
BACKGROUND:Inflammation plays a role in mood and behavior that may be relevant to identifying risk factors and treatment for depression and other stress-related illnesses. The purpose of this study was to examine whether fluctuations in inflammation following a mild immune stimulus were associated with changes in daily reported features of depression for up to a week in a healthy sample of young adults. METHODS: Forty-one undergraduate students completed daily diaries of mood, feelings of social disconnection, sleep, and physical symptoms for one week before and after receiving the seasonal influenza vaccine. Circulating plasma interleukin-6 (IL-6) was measured via blood samples taken immediately before and one day after vaccination. RESULTS: There was a significant increase in circulating IL-6 from pre- to post-intervention (p = .008), and there was significant variability in the magnitude of IL-6 change. Greater increases in IL-6 were associated with greater mood disturbance on post-vaccine days, specifically depressed mood and cognitive symptoms. CONCLUSIONS: Minor increases in inflammation were associated with corresponding increases in features of depression, and these associations occurred in the absence of any physical symptoms. The influenza vaccine could be used to probe causal relationships with a high degree of ecological validity, even in high-risk and vulnerable populations, to better understand the role of inflammation in the pathogenesis of depression.
Authors: Cara L Carty; Patrick Heagerty; Karen Nakayama; E Clair McClung; Julieann Lewis; Dawn Lum; Erin Boespflug; Carrie McCloud-Gehring; Behrooz R Soleimani; Jane Ranchalis; Tamara J Bacus; Clement E Furlong; Gail P Jarvik Journal: Arterioscler Thromb Vasc Biol Date: 2006-10-05 Impact factor: 8.311
Authors: Lucile Capuron; Jane F Gumnick; Dominique L Musselman; David H Lawson; Andrea Reemsnyder; Charles B Nemeroff; Andrew H Miller Journal: Neuropsychopharmacology Date: 2002-05 Impact factor: 7.853
Authors: Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Hugo D Critchley Journal: Biol Psychiatry Date: 2009-05-07 Impact factor: 13.382
Authors: Chloe C Boyle; Kate R Kuhlman; Larissa N Dooley; Marcie D Haydon; Theodore F Robles; Yuen-Siang Ang; Diego A Pizzagalli; Julienne E Bower Journal: Psychoneuroendocrinology Date: 2018-11-20 Impact factor: 4.905
Authors: Kate R Kuhlman; Theodore F Robles; Marcie D Haydon; Larissa Dooley; Chloe C Boyle; Julienne E Bower Journal: Dev Psychobiol Date: 2019-09-06 Impact factor: 3.038
Authors: Daniel P Moriarity; Marin M Kautz; Naoise Mac Giollabui; Joshua Klugman; Christopher L Coe; Lauren M Ellman; Lyn Y Abramson; Lauren B Alloy Journal: Clin Psychol Sci Date: 2020-05-18
Authors: E E M Knowles; Joanne E Curran; Harald H H Göring; Samuel R Mathias; Josephine Mollon; Amanda Rodrigue; Rene L Olvera; Ana Leandro; Ravi Duggirala; Laura Almasy; John Blangero; David C Glahn Journal: Brain Behav Immun Date: 2019-04-03 Impact factor: 7.217
Authors: Yara J Toenders; Liliana Laskaris; Christopher G Davey; Michael Berk; Yuri Milaneschi; Femke Lamers; Brenda W J H Penninx; Lianne Schmaal Journal: Mol Psychiatry Date: 2021-10-11 Impact factor: 15.992
Authors: Chloe C Boyle; Annette L Stanton; Naomi I Eisenberger; Teresa E Seeman; Julienne E Bower Journal: Brain Behav Immun Date: 2019-09-30 Impact factor: 7.217
Authors: Larissa N Dooley; Kate R Kuhlman; Theodore F Robles; Naomi I Eisenberger; Michelle G Craske; Julienne E Bower Journal: Neurosci Biobehav Rev Date: 2018-09-07 Impact factor: 8.989